Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 2c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Stifel on Bally's Corp (BALY): 'expect shares to continue to trade mainly on development project cost & financing updates'